How Tumor-Immune Cell Clusters Influence Breast Cancer Metastasis
New studies reveal how tumor-immune cell clusters in the bloodstream significantly enhance breast cancer metastasis, offering promising targets for early intervention.
Recent research from Northwestern University has shed light on the mechanisms driving the spread of breast cancer, emphasizing the critical role of cellular interactions in the bloodstream. In two comprehensive studies published in Nature Communications and The Journal of Clinical Investigation, scientists explored how circulating tumor cells (CTCs) form clusters with immune cells, significantly increasing their metastatic potential.
The first study identified the protein Plexin-B2 (PLXNB2) as a key factor in tumor cell clustering. Using computational algorithms, researchers found that PLXNB2 is highly expressed in multicellular CTC clusters, which are up to fifty times more efficient at establishing metastases compared to individual tumor cells. Liu, the lead researcher, explained that tumor cells traveling through the bloodstream can encounter physical and immune system hurdles. By associating with immune cells, these clusters can evade immune surveillance and enhance their ability to seed new tumors. Mouse experiments demonstrated that disrupting PLXNB2 reduced lung metastases, suggesting it could be a promising therapeutic target.
The second study focused on the immune landscape within circulating tumor clusters. Analysis of blood samples from advanced breast cancer patients revealed that over 75% of samples contained such clusters, which included rare T-cells—specifically double-positive CD4/CD8 T-cells (DPTs). These cells exhibited immunosuppressive traits, aiding tumor evasion. Researchers identified two molecules, VLA-4 on DPT cells and VCAM-1 on tumor cells, that facilitate cluster formation. Blocking this interaction in mice significantly impeded clustering and improved survival outcomes.
These groundbreaking findings highlight the dual roles of tumor cell properties and immune interactions in metastasis. Targeting key proteins like PLXNB2, or blocking the VLA-4/VCAM-1 interaction, holds potential for preventing the spread of breast cancer at early stages. This research enhances our understanding of cancer biology, revealing new avenues for therapy that could inhibit metastasis, thereby improving patient prognosis.
Source: [https://medicalxpress.com/news/2025-09-tumor-immune-cell-clusters-breast.html]
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative AI Algorithm Enhances Precision in Chemotherapy Dosing for Colorectal Cancer Patients
A groundbreaking AI algorithm is designed to personalize chemotherapy doses for colorectal cancer patients, reducing toxicity and improving treatment outcomes. Developed through collaborative efforts, it uses CT scan data to tailor therapy and aims to revolutionize cancer care.
Minimal Evidence of Fertility Risks in Men Taking Epilepsy Medication
Large-scale research indicates that sodium valproate, a common epilepsy medication, has minimal impact on male fertility, reassuring men on treatment about potential reproductive risks.
Innovative Imaging Technology Promises to Enhance Brain Cancer Surgery
A groundbreaking imaging probe developed by researchers offers real-time visualization of glioblastoma during surgery, enhancing tumor removal precision and potentially improving patient outcomes.
Effective Targeted Concussion Treatment Enhances Long-Term Quality of Life
Recent studies show that personalized concussion care can lead to full recovery and improved quality of life years after injury, emphasizing the importance of active, tailored treatment approaches.